| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-06 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0007 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.002 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |